April 24, 2017 / 12:34 PM / 3 months ago

BRIEF-Immune receives nasdaq letter

1 Min Read

April 24 (Reuters) - Immune Pharmaceuticals Inc

* Immune receives Nasdaq letter

* Got notice from listing qualifications department of Nasdaq notifying that Co does not comply with Nasdaq's filing requirements Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below